Atrial fibrillation prevention: an appraisal of current evidence
Atrial fibrillation (AF), which is the most diagnosed arrhythmia, is becoming a significant issue for health policy-makers. In particular, more and more attention is being devoted to AF prevention. Indeed, several studies recently published point out how targeted interventions could be useful in red...
Uloženo v:
| Vydáno v: | Heart (British Cardiac Society) Ročník 104; číslo 11; s. 882 - 887 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
BMJ Publishing Group LTD
01.06.2018
|
| Témata: | |
| ISSN: | 1355-6037, 1468-201X, 1468-201X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Atrial fibrillation (AF), which is the most diagnosed arrhythmia, is becoming a significant issue for health policy-makers. In particular, more and more attention is being devoted to AF prevention. Indeed, several studies recently published point out how targeted interventions could be useful in reducing the risk of AF occurrence (or recurrence). In this review, we briefly summarised the role of the major risk factors associated with the incidence of AF, as well as the effectiveness of interventions aimed at controlling these risk factors. Several general risk factors, such as alcohol consumption, physical activity, smoking habit, as well as specific cardiovascular risk factors as diabetes mellitus, hypertension and obesity have a relevant impact in determining the occurrence of AF, along with a strong clinical evidence of a dose–effect response mechanism for most of the factors examined. Specific interventions aimed at controlling risk factors have been showed to clearly reduce the risk of AF in several cohorts. Even more importantly, integrated programmes aimed at controlling for multiple risk factors would be more efficient in terms of reducing risk of AF, in particular whena stricter control is observed. AF prevention requires a series of initiatives focused on the many risk factors that we reviewed, as well as a more integrated approach, which should involve many stakeholders at different levels. In this light and also considering the constantly changing epidemiology, AF prevention may constitute a future ‘win–win’ strategy for all the stakeholders. |
|---|---|
| AbstractList | Atrial fibrillation (AF), which is the most diagnosed arrhythmia, is becoming a significant issue for health policy-makers. In particular, more and more attention is being devoted to AF prevention. Indeed, several studies recently published point out how targeted interventions could be useful in reducing the risk of AF occurrence (or recurrence). In this review, we briefly summarised the role of the major risk factors associated with the incidence of AF, as well as the effectiveness of interventions aimed at controlling these risk factors. Several general risk factors, such as alcohol consumption, physical activity, smoking habit, as well as specific cardiovascular risk factors as diabetes mellitus, hypertension and obesity have a relevant impact in determining the occurrence of AF, along with a strong clinical evidence of a dose-effect response mechanism for most of the factors examined. Specific interventions aimed at controlling risk factors have been showed to clearly reduce the risk of AF in several cohorts. Even more importantly, integrated programmes aimed at controlling for multiple risk factors would be more efficient in terms of reducing risk of AF, in particular whena stricter control is observed. AF prevention requires a series of initiatives focused on the many risk factors that we reviewed, as well as a more integrated approach, which should involve many stakeholders at different levels. In this light and also considering the constantly changing epidemiology, AF prevention may constitute a future 'win-win' strategy for all the stakeholders. Atrial fibrillation (AF), which is the most diagnosed arrhythmia, is becoming a significant issue for health policy-makers. In particular, more and more attention is being devoted to AF prevention. Indeed, several studies recently published point out how targeted interventions could be useful in reducing the risk of AF occurrence (or recurrence). In this review, we briefly summarised the role of the major risk factors associated with the incidence of AF, as well as the effectiveness of interventions aimed at controlling these risk factors. Several general risk factors, such as alcohol consumption, physical activity, smoking habit, as well as specific cardiovascular risk factors as diabetes mellitus, hypertension and obesity have a relevant impact in determining the occurrence of AF, along with a strong clinical evidence of a dose-effect response mechanism for most of the factors examined. Specific interventions aimed at controlling risk factors have been showed to clearly reduce the risk of AF in several cohorts. Even more importantly, integrated programmes aimed at controlling for multiple risk factors would be more efficient in terms of reducing risk of AF, in particular whena stricter control is observed. AF prevention requires a series of initiatives focused on the many risk factors that we reviewed, as well as a more integrated approach, which should involve many stakeholders at different levels. In this light and also considering the constantly changing epidemiology, AF prevention may constitute a future 'win-win' strategy for all the stakeholders.Atrial fibrillation (AF), which is the most diagnosed arrhythmia, is becoming a significant issue for health policy-makers. In particular, more and more attention is being devoted to AF prevention. Indeed, several studies recently published point out how targeted interventions could be useful in reducing the risk of AF occurrence (or recurrence). In this review, we briefly summarised the role of the major risk factors associated with the incidence of AF, as well as the effectiveness of interventions aimed at controlling these risk factors. Several general risk factors, such as alcohol consumption, physical activity, smoking habit, as well as specific cardiovascular risk factors as diabetes mellitus, hypertension and obesity have a relevant impact in determining the occurrence of AF, along with a strong clinical evidence of a dose-effect response mechanism for most of the factors examined. Specific interventions aimed at controlling risk factors have been showed to clearly reduce the risk of AF in several cohorts. Even more importantly, integrated programmes aimed at controlling for multiple risk factors would be more efficient in terms of reducing risk of AF, in particular whena stricter control is observed. AF prevention requires a series of initiatives focused on the many risk factors that we reviewed, as well as a more integrated approach, which should involve many stakeholders at different levels. In this light and also considering the constantly changing epidemiology, AF prevention may constitute a future 'win-win' strategy for all the stakeholders. |
| Author | Boriani, Giuseppe Proietti, Marco |
| Author_xml | – sequence: 1 givenname: Giuseppe surname: Boriani fullname: Boriani, Giuseppe email: giuseppe.boriani@unimore.it organization: Cardiology Division, Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy – sequence: 2 givenname: Marco surname: Proietti fullname: Proietti, Marco email: giuseppe.boriani@unimore.it organization: Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29191806$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkU1LxDAQhoMoun78A5GCFy91M02aNHtSxC9Y8KLgLaRpiindtCat4L83te7Fi55mmHneYXjfQ7TrOmcQOgV8CUDY8s0oPzSuTTMMPCUAOWU7aAGUFdPodTf2JM9Thgk_QIchNBhjKgq2jw4yAQIKzBbo6nrwVrVJbUtv21YNtnNJ782HcVO7SpRLVN97ZUOkujrRo_dxl5gPWxmnzTHaq1UbzMlPPUIvd7fPNw_p-un-8eZ6nZa04EOqakaKSpVYaJqzLGNc84LQWtcMi4powIQCLQwFpkqisa5EWWcEF4ArrnVJjtDFfLf33ftowiA3NmgTX3amG4MEwYFRinkW0fNfaNON3sXvZIaJ4ARyISJ19kON5cZUsvd2o_yn3HoTgdUMaN-F4E0ttR2-DRqiHa0ELKcg5DYIOQUh5yCimP4Sb-__IVvOsnLT_E_xBf8wnNQ |
| CitedBy_id | crossref_primary_10_1007_s40256_019_00374_0 crossref_primary_10_1186_s13643_019_1128_z crossref_primary_10_14797_mdcvj_1516 crossref_primary_10_3389_fcvm_2021_726694 crossref_primary_10_3390_jcm13030679 crossref_primary_10_1016_j_ejim_2023_10_023 crossref_primary_10_1016_j_ijcard_2017_12_036 crossref_primary_10_1016_j_amjmed_2018_06_012 crossref_primary_10_1136_heartjnl_2018_313764 crossref_primary_10_1186_s12916_021_02120_3 crossref_primary_10_1136_heartjnl_2018_313443 crossref_primary_10_1016_j_medcle_2025_106908 crossref_primary_10_1093_europace_euaf026 crossref_primary_10_1016_j_ijcard_2018_07_006 crossref_primary_10_1177_2047487319877469 crossref_primary_10_3389_fcvm_2022_1032633 crossref_primary_10_1016_j_ejim_2022_06_017 crossref_primary_10_1186_s12872_021_01942_6 crossref_primary_10_1111_echo_14315 crossref_primary_10_5761_atcs_ra_21_00126 crossref_primary_10_1007_s43657_023_00151_9 crossref_primary_10_1016_j_medcli_2025_106908 crossref_primary_10_1016_j_mayocp_2019_06_012 crossref_primary_10_3389_fmed_2020_592901 |
| Cites_doi | 10.1161/CIRCULATIONAHA.110.009035 10.1093/eurheartj/eht507 10.1016/j.ijcard.2015.05.011 10.1093/eurheartj/ehv486 10.1016/j.jacc.2017.02.020 10.1093/europace/euw112 10.1056/NEJMoa1313600 10.1161/CIRCULATIONAHA.116.026693 10.1161/CIR.0000000000000485 10.1161/CIRCULATIONAHA.116.023163 10.1093/eurheartj/ehi825 10.1016/j.jacc.2004.10.068 10.1016/j.chest.2015.08.018 10.1016/j.jacc.2015.06.488 10.1093/eurheartj/ehv375 10.1016/j.jacc.2010.08.641 10.1136/bmj.i4482 10.1001/jama.2013.280521 10.1016/j.vph.2016.03.006 10.1016/j.jacc.2014.09.028 10.1378/chest.14-1565 10.1001/jamacardio.2016.0393 10.1093/eurheartj/ehi651 10.1007/s00392-015-0936-y 10.1016/j.jacc.2014.03.048 10.1378/chest.12-1091 10.1016/j.amjmed.2016.06.045 10.2174/1381612820666140825142639 10.1161/CIRCRESAHA.115.306841 10.1016/j.amjmed.2014.11.026 10.1016/j.jacc.2015.03.002 10.1161/CIRCULATIONAHA.113.005119 10.1177/2047487316676037 10.7326/0003-4819-158-5-201303050-00007 10.1093/eurheartj/ehw210 10.1093/europace/euv233 10.1093/eurheartj/ehw058 |
| ContentType | Journal Article |
| Copyright | Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Copyright: 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. |
| Copyright_xml | – notice: Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. – notice: Copyright: 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. M0S M1P M2P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 |
| DOI | 10.1136/heartjnl-2017-311546 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Central Student MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-201X |
| EndPage | 887 |
| ExternalDocumentID | 29191806 10_1136_heartjnl_2017_311546 heartjnl |
| Genre | Systematic Review Journal Article |
| GroupedDBID | --- .55 .VT 0R~ 29I 2WC 354 39C 3O- 4.4 40O 53G 5GY 5RE 7X7 7~S 88E 88I 8AF 8FI 8FJ 8R4 8R5 AAFWJ AAHLL AAKAS AAOJX AAWJN AAWTL AAYEP ABAAH ABJNI ABKDF ABMQD ABOCM ABUWG ABVAJ ACGFS ACGOD ACGTL ACHTP ACMFJ ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADUGQ ADZCM AEKJL AENEX AFFNX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ AKKEP ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZFZN AZQEC BAWUL BCR BENPR BLC BLJBA BOMFT BPHCQ BTHHO BVXVI C1A CAG CCPQU COF CXRWF DIK DU5 DWQXO E3Z EBS EJD EX3 F5P FEDTE FYUFA GNUQQ GX1 H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IHR INH INR IOF ITC J5H L7B M1P M2P N4W N9A NTWIH NXWIF O9- OK1 OVD P2P PCD PEA PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UKHRP UYXKK V24 VM9 WH7 WOQ WOW X7M YFH YQY ZGI ZXP AAYXX ACQHZ AERUA AFFHD CITATION PHGZM PJZUB PPXIY ADGHP CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO |
| ID | FETCH-LOGICAL-b487t-af638dab09c4562267c7834fcf609d3c1034148e416ab3c0cd9bf230810d7ccb3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 28 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000433238900006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1355-6037 1468-201X |
| IngestDate | Fri Sep 05 11:39:46 EDT 2025 Tue Oct 07 06:53:10 EDT 2025 Mon Jul 21 06:06:11 EDT 2025 Tue Nov 18 22:17:15 EST 2025 Sat Nov 29 07:28:53 EST 2025 Thu Apr 24 23:08:48 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | epidemiology atrial fibrillation cardiac risk factors and prevention stroke obesity |
| Language | English |
| License | Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b487t-af638dab09c4562267c7834fcf609d3c1034148e416ab3c0cd9bf230810d7ccb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | http://hdl.handle.net/11380/1167979 |
| PMID | 29191806 |
| PQID | 2039731599 |
| PQPubID | 2041068 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1971644072 proquest_journals_2039731599 pubmed_primary_29191806 crossref_citationtrail_10_1136_heartjnl_2017_311546 crossref_primary_10_1136_heartjnl_2017_311546 bmj_primary_10_1136_heartjnl_2017_311546 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-06-01 |
| PublicationDateYYYYMMDD | 2018-06-01 |
| PublicationDate_xml | – month: 06 year: 2018 text: 2018-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Heart (British Cardiac Society) |
| PublicationTitleAlternate | Heart |
| PublicationYear | 2018 |
| Publisher | BMJ Publishing Group LTD |
| Publisher_xml | – name: BMJ Publishing Group LTD |
| References | Freedman, Martinez, Katholing 2016; 1 Gorenek (chair), Pelliccia (co-chair), Benjamin 2017; 24 Huxley, Lopez, Folsom 2011; 123 Kodama, Saito, Tanaka 2011; 57 Nalliah, Sanders, Kottkamp 2016; 37 Boriani, Valzania, Biffi 2015; 21 Wendelboe, Raskob 2016; 118 Heeringa, van der Kuip, Hofman 2006; 27 Freedman, Camm, Calkins 2017; 135 Boriani 2015; 147 Abed, Wittert, Leong 2013; 310 Benjamin, Blaha, Chiuve 2017; 135 Pathak, Middeldorp, Lau 2014; 64 Chugh, Havmoeller, Narayanan 2014; 129 Fauchier, Villejoubert, Clementy 2016; 129 Sanna, Diener, Passman 2014; 370 Lane, Aguinaga, Blomström-Lundqvist 2015; 17 Boriani, Diemberger 2012; 142 Kirchhof, Benussi, Kotecha 2016; 37 Marott, Nielsen, Benn 2014; 35 Proietti, Laroche, Opolski 2017; 19 Wachtell, Lehto, Gerdts 2005; 45 Xiong, Proietti, Senoo 2015; 191 Larsson, Drca, Wolk 2014; 64 Lau, Nattel, Kalman 2017; 136 Boriani 2016; 149 Heidbuchel, Verhamme, Alings 2016 Kalantarian, Stern, Mansour 2013; 158 Pathak, Middeldorp, Meredith 2015; 65 Du, Dong, Ma 2017; 69 Odutayo, Wong, Hsiao 2016; 354 Boriani, Pettorelli 2016; 83 Pathak, Elliott, Middeldorp 2015; 66 Boriani, Laroche, Diemberger 2015; 128 Boriani, Diemberger, Martignani 2006; 27 Proietti, Raparelli, Olshansky 2016; 105 Lau, Schotten, Mahajan 2016; 37 Freedman (2025092022190912000_104.11.882.7) 2016; 1 2025092022190912000_104.11.882.18 2025092022190912000_104.11.882.17 2025092022190912000_104.11.882.16 2025092022190912000_104.11.882.15 2025092022190912000_104.11.882.37 2025092022190912000_104.11.882.14 2025092022190912000_104.11.882.36 2025092022190912000_104.11.882.13 2025092022190912000_104.11.882.35 2025092022190912000_104.11.882.12 2025092022190912000_104.11.882.34 Boriani (2025092022190912000_104.11.882.39) 2016; 83 2025092022190912000_104.11.882.11 2025092022190912000_104.11.882.33 2025092022190912000_104.11.882.1 2025092022190912000_104.11.882.31 2025092022190912000_104.11.882.2 2025092022190912000_104.11.882.30 2025092022190912000_104.11.882.3 Fauchier (2025092022190912000_104.11.882.6) 2016; 129 2025092022190912000_104.11.882.5 2025092022190912000_104.11.882.8 2025092022190912000_104.11.882.9 Boriani (2025092022190912000_104.11.882.38) 2015; 21 Boriani (2025092022190912000_104.11.882.4) 2016; 149 2025092022190912000_104.11.882.19 2025092022190912000_104.11.882.29 2025092022190912000_104.11.882.28 2025092022190912000_104.11.882.27 2025092022190912000_104.11.882.26 2025092022190912000_104.11.882.25 2025092022190912000_104.11.882.24 2025092022190912000_104.11.882.23 2025092022190912000_104.11.882.22 2025092022190912000_104.11.882.21 2025092022190912000_104.11.882.20 Proietti (2025092022190912000_104.11.882.10) 2017; 19 Boriani (2025092022190912000_104.11.882.32) 2015; 147 |
| References_xml | – volume: 123 start-page: 1501 year: 2011 article-title: Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.009035 – volume: 35 start-page: 1205 year: 2014 article-title: Antihypertensive treatment and risk of atrial fibrillation: a nationwide study publication-title: Eur Heart J doi: 10.1093/eurheartj/eht507 – volume: 191 start-page: 172 year: 2015 article-title: Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age/gender differences and cardiovascular outcomes publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2015.05.011 – volume: 37 start-page: 1565 year: 2016 article-title: The role of obesity in atrial fibrillation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv486 – volume: 69 start-page: 1968 year: 2017 article-title: Is atrial fibrillation a preventable disease? publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2017.02.020 – volume: 19 start-page: 722 year: 2017 article-title: ’Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational research programme-atrial fibrillation general registry pilot phase publication-title: Europace doi: 10.1093/europace/euw112 – volume: 370 start-page: 2478 year: 2014 article-title: Cryptogenic stroke and underlying atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1313600 – volume: 135 start-page: 1851 year: 2017 article-title: Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.026693 – volume: 135 start-page: e146 year: 2017 article-title: Heart disease and stroke statistics-2017 update: a report from the american heart association publication-title: Circulation doi: 10.1161/CIR.0000000000000485 – volume: 136 start-page: 583 year: 2017 article-title: Modifiable risk factors and atrial fibrillation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.023163 – volume: 27 start-page: 949 year: 2006 article-title: Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi825 – volume: 45 start-page: 712 year: 2005 article-title: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the losartan intervention For end point reduction in hypertension (LIFE) study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2004.10.068 – volume: 149 start-page: 301 year: 2016 article-title: Atrial fibrillation and aging: risky mutual relationships publication-title: Chest doi: 10.1016/j.chest.2015.08.018 – volume: 66 start-page: 985 year: 2015 article-title: Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.06.488 – volume: 37 start-page: 1573 year: 2016 article-title: Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv375 – volume: 57 start-page: 427 year: 2011 article-title: Alcohol consumption and risk of atrial fibrillation: a meta-analysis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.08.641 – volume: 354 start-page: i4482 year: 2016 article-title: Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis publication-title: BMJ doi: 10.1136/bmj.i4482 – volume: 310 start-page: 2050 year: 2013 article-title: Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2013.280521 – volume: 83 start-page: 26 year: 2016 article-title: Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation publication-title: Vascul Pharmacol doi: 10.1016/j.vph.2016.03.006 – volume: 64 start-page: 2222 year: 2014 article-title: Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.09.028 – volume: 147 start-page: 9 year: 2015 article-title: The epidemiologic threat of atrial fibrillation publication-title: Chest doi: 10.1378/chest.14-1565 – volume: 1 start-page: 366 year: 2016 article-title: Residual risk of stroke and death in anticoagulant-treated patients with atrial fibrillation publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2016.0393 – volume: 27 start-page: 893 year: 2006 article-title: The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi651 – volume: 105 start-page: 412 year: 2016 article-title: Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial publication-title: Clin Res Cardiol doi: 10.1007/s00392-015-0936-y – volume: 64 start-page: 281 year: 2014 article-title: Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.03.048 – volume: 142 start-page: 1368 year: 2012 article-title: Globalization of the epidemiologic, clinical, and financial burden of atrial fibrillation publication-title: Chest doi: 10.1378/chest.12-1091 – volume: 129 start-page: 1278 year: 2016 article-title: Causes of death and influencing factors in patients with atrial fibrillation publication-title: Am J Med doi: 10.1016/j.amjmed.2016.06.045 – volume: 21 start-page: 659 year: 2015 article-title: Asymptomatic lone atrial fibrillation - how can we detect the arrhythmia? publication-title: Curr Pharm Des doi: 10.2174/1381612820666140825142639 – volume: 118 start-page: 1340 year: 2016 article-title: Global burden of thrombosis: epidemiologic aspects publication-title: Circ Res doi: 10.1161/CIRCRESAHA.115.306841 – volume: 128 start-page: 509 year: 2015 article-title: Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry publication-title: Am J Med doi: 10.1016/j.amjmed.2014.11.026 – volume: 65 start-page: 2159 year: 2015 article-title: Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a Long-Term Follow-Up Study (LEGACY) publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.03.002 – volume: 129 start-page: 837 year: 2014 article-title: Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.005119 – volume: 24 start-page: 4 year: 2017 article-title: European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) publication-title: Eur J Prev Cardiol doi: 10.1177/2047487316676037 – volume: 158 start-page: 338 year: 2013 article-title: Cognitive impairment associated with atrial fibrillation: a meta-analysis publication-title: Ann Intern Med doi: 10.7326/0003-4819-158-5-201303050-00007 – volume: 37 start-page: 2893 year: 2016 article-title: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw210 – volume: 17 start-page: 1747 year: 2015 article-title: Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) publication-title: Europace doi: 10.1093/europace/euv233 – year: 2016 article-title: Updated european heart rhythm association practical guide on the use of non-vitamin-k antagonist anticoagulants in patients with non-valvular atrial fibrillation: executive summary publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw058 – ident: 2025092022190912000_104.11.882.35 doi: 10.1016/j.jacc.2004.10.068 – ident: 2025092022190912000_104.11.882.1 doi: 10.1161/CIR.0000000000000485 – volume: 83 start-page: 26 year: 2016 ident: 2025092022190912000_104.11.882.39 article-title: Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation publication-title: Vascul Pharmacol doi: 10.1016/j.vph.2016.03.006 – ident: 2025092022190912000_104.11.882.2 doi: 10.1161/CIRCULATIONAHA.113.005119 – ident: 2025092022190912000_104.11.882.18 doi: 10.1161/CIRCULATIONAHA.116.023163 – ident: 2025092022190912000_104.11.882.29 doi: 10.1093/eurheartj/ehv375 – ident: 2025092022190912000_104.11.882.3 doi: 10.1093/eurheartj/ehi651 – ident: 2025092022190912000_104.11.882.20 doi: 10.1093/eurheartj/ehw210 – ident: 2025092022190912000_104.11.882.27 doi: 10.1016/j.jacc.2015.03.002 – volume: 19 start-page: 722 year: 2017 ident: 2025092022190912000_104.11.882.10 article-title: ’Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational research programme-atrial fibrillation general registry pilot phase publication-title: Europace – ident: 2025092022190912000_104.11.882.23 doi: 10.1016/j.jacc.2010.08.641 – ident: 2025092022190912000_104.11.882.12 doi: 10.1378/chest.12-1091 – volume: 147 start-page: 9 year: 2015 ident: 2025092022190912000_104.11.882.32 article-title: The epidemiologic threat of atrial fibrillation publication-title: Chest doi: 10.1378/chest.14-1565 – ident: 2025092022190912000_104.11.882.22 doi: 10.1093/europace/euv233 – ident: 2025092022190912000_104.11.882.15 doi: 10.1177/2047487316676037 – ident: 2025092022190912000_104.11.882.13 – ident: 2025092022190912000_104.11.882.5 doi: 10.1161/CIRCRESAHA.115.306841 – ident: 2025092022190912000_104.11.882.34 doi: 10.1093/eurheartj/eht507 – ident: 2025092022190912000_104.11.882.8 doi: 10.1136/bmj.i4482 – ident: 2025092022190912000_104.11.882.33 doi: 10.1093/eurheartj/ehi825 – ident: 2025092022190912000_104.11.882.24 doi: 10.1016/j.jacc.2014.03.048 – ident: 2025092022190912000_104.11.882.25 doi: 10.1093/eurheartj/ehv486 – volume: 1 start-page: 366 year: 2016 ident: 2025092022190912000_104.11.882.7 article-title: Residual risk of stroke and death in anticoagulant-treated patients with atrial fibrillation publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2016.0393 – ident: 2025092022190912000_104.11.882.26 doi: 10.1016/j.jacc.2015.06.488 – ident: 2025092022190912000_104.11.882.11 doi: 10.7326/0003-4819-158-5-201303050-00007 – ident: 2025092022190912000_104.11.882.31 doi: 10.1161/CIRCULATIONAHA.110.009035 – ident: 2025092022190912000_104.11.882.36 doi: 10.1056/NEJMoa1313600 – ident: 2025092022190912000_104.11.882.28 doi: 10.1001/jama.2013.280521 – ident: 2025092022190912000_104.11.882.17 doi: 10.1016/j.ijcard.2015.05.011 – ident: 2025092022190912000_104.11.882.21 doi: 10.1093/eurheartj/ehw058 – ident: 2025092022190912000_104.11.882.9 doi: 10.1007/s00392-015-0936-y – ident: 2025092022190912000_104.11.882.19 doi: 10.1016/j.jacc.2017.02.020 – ident: 2025092022190912000_104.11.882.30 doi: 10.1016/j.jacc.2014.09.028 – ident: 2025092022190912000_104.11.882.16 doi: 10.1016/j.amjmed.2014.11.026 – volume: 129 start-page: 1278 year: 2016 ident: 2025092022190912000_104.11.882.6 article-title: Causes of death and influencing factors in patients with atrial fibrillation publication-title: Am J Med doi: 10.1016/j.amjmed.2016.06.045 – ident: 2025092022190912000_104.11.882.14 – ident: 2025092022190912000_104.11.882.37 doi: 10.1161/CIRCULATIONAHA.116.026693 – volume: 149 start-page: 301 year: 2016 ident: 2025092022190912000_104.11.882.4 article-title: Atrial fibrillation and aging: risky mutual relationships publication-title: Chest doi: 10.1016/j.chest.2015.08.018 – volume: 21 start-page: 659 year: 2015 ident: 2025092022190912000_104.11.882.38 article-title: Asymptomatic lone atrial fibrillation - how can we detect the arrhythmia? publication-title: Curr Pharm Des doi: 10.2174/1381612820666140825142639 |
| SSID | ssj0004986 |
| Score | 2.4119205 |
| SecondaryResourceType | review_article |
| Snippet | Atrial fibrillation (AF), which is the most diagnosed arrhythmia, is becoming a significant issue for health policy-makers. In particular, more and more... |
| SourceID | proquest pubmed crossref bmj |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 882 |
| SubjectTerms | Atrial Fibrillation - prevention & control Humans Primary Prevention Risk Factors Risk Reduction Behavior Secondary Prevention Tertiary Prevention |
| Title | Atrial fibrillation prevention: an appraisal of current evidence |
| URI | https://heart.bmj.com/content/104/11/882.full https://www.ncbi.nlm.nih.gov/pubmed/29191806 https://www.proquest.com/docview/2039731599 https://www.proquest.com/docview/1971644072 |
| Volume | 104 |
| WOSCitedRecordID | wos000433238900006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1468-201X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004986 issn: 1355-6037 databaseCode: BENPR dateStart: 19960101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection (NC LIVE) customDbUrl: eissn: 1468-201X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004986 issn: 1355-6037 databaseCode: 7X7 dateStart: 19960101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1468-201X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004986 issn: 1355-6037 databaseCode: M2P dateStart: 19960101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB6VpUJcgJbX8lIq9cDFqrMOjs2FR7Woh7JaVS3am5XYsQRakoXs8vuZSbyLegAq9RIpSvyQZ-yZscffB_DVSy8T7i2TjhcsiV2Mc07ljHs039qjhW-Sx29-poOBGo30MGy41SGtcr4mNgu1qyztkWOQLohl6UTrs8kDI9YoOl0NFBpLsExIZUkHli_7g-Gvl5uRuuF6jNGqMslFGi7PxUJ-I8Lo6V05Rj2JaasOfQnCHcnv7_42Ua_4nY39uVr_355vwFrwPKOLVlU-wYei_Awr1-FsfRPOLxoGj8jTJYBxmyIXTQLCU1WeRlkZEQJ5dlvjX5WPbAvtFBWBmHQL_lz1f3__wQK_AssxTJmyzOPkc1nOtaU4qCdTS7Qb3nrJtRM25mjiElWgz5blwnLrdI4iRCeCu9TaXGxDp6zKYhci_HbCCTcGa0yc0kq5xEqRZ4nACLTodeEYB9ZMWgQN00QeQpq5DAzJwLQy6IKYj76xAaec6DLG75Rii1L_1srBXFgmzNravEiqC18Wn3G-0SFKVhbVrDYxYW4lBCvXhZ1WIRYN9jRGv4rLvbcr34dV7IlqE84OoDN9nBWH8NE-TW_rxyNYSkdp81RHQZ3x7bo3fAZh3vkw |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LTxRBEK4gGOXiW1xBbRNNuHTsmR56p00MEpVA2N1wQMOtmelHsmSZWZkFwp_yN1o1jyUcVC4cPM_0Y6be3VX1AbwLKqhEBMuVE54nkYtQ5tKci4DmWwe08HXy-I9BfzRKDw_1_gL86mphKK2y04m1onalpTNyDNIloSxtaL05_ckJNYpuVzsIjYYt9vzlBYZs1afdr0jf93G8_e3gyw5vUQV4js75jGcBWc5ludCWvP9Y9S2BTQQblNBO2kigYk9Sj55KlksrrNM5bhxNp3B9a3OJ896BpQQjIZKrYbx_VYepa2TJCG04V0L221K9SKoPBE89Oy4myJURHQyi50JdTvKT4-sG8Q9ebm3tth_-b__pETxo_Wq21QjCY1jwxRO4N2wzB57C560an4QFKnGYNAmAbNr2ryqLjywrGPVXz8YVvlUGZpvGVcy3sKvP4Put7P85LBZl4V8Aw2cbgrri4IyJS3WausQqmWeJxPjaxz1YR0KaadMfxNRxlVSmo7khmpuG5j2QHbWNbbuwExjI5B-j-HzUzVZZ65jDtDqpMlec0YO388eoTeiKKCt8eVaZiDqKEWvjN600DDhfMNYY26dCvfz75G_g_s7BcGAGu6O9VVjGXaVNat0aLM5Oz_wruGvPZ-Pq9HUtPAyObpsLfwPHdlGi |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgiouvB8LBYwEEherTpx1YiQEFWVF1Xa1B0C9uYkfUqslWZotiL_Gr2MmcbbiwOPSA-fEj2TG87DH3wfwLKigMhEsV054niUuwTVXVFwEdN86oIfvisc_7efTaXF4qGdr8GO4C0NllYNN7Ay1ayztkWOSLollaaz1VohlEbOdyevFF04MUnTSOtBp9Cqy579_w_StfbW7g7J-nqaTdx_evueRYYBXGKgveRlQ_VxZCW0pE0hVbol4ItighHbSJgKNfFZ4jFrKSlphna7wI9CNCpdbW0ns9xJczrPxmMoJD9LZ-Z1M3bFMJujPuRIyj9f2Eqm2iKp6eVLPUUMT2iTEKIYQT6rPJ786x99EvJ3nm1z_n__ZDbgW42223S-Qm7Dm61uwcRArCm7Dm-2Ot4QFuvow7wsD2SLiWjX1S1bWjHDXy-MW32oCsz2gFfORjvUOfLyQ-d-F9bqp_X1g-GwsCC0He8xcoYvCZVbJqswk5t0-HcELFKpZ9Lghpsu3pDKD_A3J3_TyH4EcJG9sRGcnkpD5X1rxVat_G2VzUBQTbVVrzrVkBE9Xj9HK0NFRWfvmrDUJIY1lBKY3gnu9Mq4GTDXm_IVQD_7c-RPYQOUz-7vTvYdwFSdV9BV3m7C-PD3zj-CK_bo8bk8fd-uIwdFFK-FPLJBaaA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Atrial+fibrillation+prevention%3A+an+appraisal+of+current+evidence&rft.jtitle=Heart+%28British+Cardiac+Society%29&rft.au=Boriani%2C+Giuseppe&rft.au=Proietti%2C+Marco&rft.date=2018-06-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=1355-6037&rft.eissn=1468-201X&rft.volume=104&rft.issue=11&rft.spage=882&rft_id=info:doi/10.1136%2Fheartjnl-2017-311546&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-6037&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-6037&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-6037&client=summon |